Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)

Jan Beneš(Institute of Clinical and Experimental Medicine), Vojtěch Melenovský(Institute for Environmental Policy)
Zenodo (CERN European Organization for Nuclear Research)
July 22, 2022
10.5281/zenodo.7553344
Cited by 0

Related Papers

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693
Baseline Characteristics of Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial
|European Journal of Heart Failure|2024|62
Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)
|Scientific Reports|2022|29
Metformin in the management of patients with diabetes and advanced heart failure (HFrEF): a propensity score-matched analysis
|Research Square|2022|0